Published in Am J Pathol on July 01, 1985
Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med (2000) 2.19
Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice. Proc Natl Acad Sci U S A (1995) 1.54
A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J Am Soc Nephrol (2011) 1.07
Adenosine and bone metabolism. Trends Endocrinol Metab (2013) 1.02
Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID). Biologics (2009) 1.01
Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency. J Clin Immunol (2012) 0.94
Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency. Blood (2011) 0.90
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol Ther (2013) 0.90
Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations. Am J Pathol (1989) 0.83
Adenosine Deaminase Deficiency - More Than Just an Immunodeficiency. Front Immunol (2016) 0.78
Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome. J Clin Immunol (2015) 0.76
Acquired chondronecrosis. Ann Rheum Dis (1990) 0.76
Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies. Arch Dis Child (1988) 0.75
Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet (1972) 9.01
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A (1981) 2.66
Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency. J Biol Chem (1978) 2.56
Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med (1975) 2.35
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med (1976) 2.04
Congenital nephrotic syndrome of Finnish type. Study of 75 patients. Arch Dis Child (1976) 1.73
Adenosine-deaminase deficiency and combined immunodeficiency syndrome. Lancet (1972) 1.62
Absence of erythrocyte adenosine deaminase associated with severe combined immunodeficiency. J Pediatr (1974) 1.46
A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol (1982) 1.39
Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med (1980) 1.32
Immunohistochemistry of adenosine deaminase: implications for adenosine neurotransmission. Science (1984) 1.25
Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome. N Engl J Med (1983) 1.25
Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J Clin Invest (1981) 1.25
Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. J Clin Invest (1980) 1.10
[Heterogeneity of early onset nephrotic syndromes in infants (nephrotic syndrome "in infants"). Anatomical, clinical and genetic study of 37 cases]. Helv Paediatr Acta (1973) 1.09
Adenosine deaminase deficiency in a child with severe combined immunodeficiency. Clin Genet (1973) 1.09
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr (1976) 1.08
Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency. Clin Exp Immunol (1984) 1.03
Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency. Albany, New York, on October 1, 1973. Clin Immunol Immunopathol (1974) 1.01
Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation. J Clin Invest (1978) 0.99
Adenosine deaminase deficiency: frequency and comparative pathology in autosomally recessive severe combined immunodeficiency. Clin Immunol Immunopathol (1979) 0.96
Animal model for immune dysfunction associated with adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1980) 0.93
Antibodies to nucleic acids in congenital immune deficiency states. J Pediatr (1976) 0.92
Effects of deoxycoformycin in mice. I. Suppression and enhancement of in vivo antibody responses to thymus-dependent and -independent antigens. J Immunol (1984) 0.89
In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin. Cancer Chemother Pharmacol (1978) 0.89
Immunological and biochemical profiles in response to transfusion therapy in an adenosine deaminase-deficient patient with severe combined immunodeficiency disease. Clin Immunol Immunopathol (1979) 0.88
The prevalence of autoantibodies in T-cell, B-cell, and phagocytic immunodeficiency disorders. Clin Immunol Immunopathol (1979) 0.88
Increased excretion of modified adenine nucleosides by children with adenosine deaminase deficiency. Pediatr Res (1982) 0.87
Effects of 2'-deoxycoformycin infusion on mouse adenosine deaminase. Cancer Res (1979) 0.87
Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor. Clin Immunol Immunopathol (1981) 0.86
Effects of deoxycoformycin in mice. III. A murine model reproducing multi-system pathology of human adenosine deaminase deficiency. Am J Pathol (1985) 0.83
Immunosuppression by 2' deoxycoformycin: studies on the mode of administration. Cell Immunol (1981) 0.83
Mesangiolytic glomerulonephritis in an infant with immune deficiency and echovirus infection. Arch Pathol Lab Med (1977) 0.83
Congenital glomerulosclerosis and nephrotic syndrome in two infants. Speculations and pathogenesis. Am J Dis Child (1979) 0.82
Familial early-onset nephrotic syndrome: diffuse mesangial sclerosis. Clinico-pathological study of a kindred. Acta Paediatr Scand (1982) 0.80
Clinical delineation of adenosine deaminase deficiency. Ciba Found Symp (1978) 0.79
Intrarenal blood flow distribution during adenosine-mediated vasoconstriction. Am J Physiol (1983) 0.79
Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes. J Immunol (1984) 0.79
Anti-Sdx: a "new" auto-agglutinin related to the Sda blood group. Transfusion (1980) 0.78
Partial resolution of bone lesions. A child with severe combined immunodeficiency disease and adenosine deaminase deficiency after enzyme-replacement therapy. Am J Dis Child (1980) 0.78
Chondroosseous histopathology in adenosine deaminase deficient combined immunodeficiency disease. Birth Defects Orig Artic Ser (1976) 0.78
Infantile nephrotic syndrome with diffuse mesangial sclerosis: a disturbance of glomerular basement membrane development? Clin Nephrol (1980) 0.77
Infantile nephrotic syndrome. Clin Nephrol (1976) 0.77
Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity (1994) 5.06
Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes. J Cell Biol (1968) 4.22
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med (1997) 3.65
Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. Proc Natl Acad Sci U S A (1986) 3.49
Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr (1973) 3.44
The search for heterogeneity in insulin-dependent diabetes mellitus (IDDM): linkage studies, two-locus models, and genetic heterogeneity. Am J Hum Genet (1983) 3.23
Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet (1995) 2.93
Genetic and clinical heterogeneity in the oral-facial-digital syndromes. J Pediatr (1967) 2.92
Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc Natl Acad Sci U S A (1978) 2.78
An immunofluorescent study of pathogenic mechanisms in glomerular diseases. N Engl J Med (1966) 2.70
Pachydermoperiostosis: an update. Clin Genet (2005) 2.65
Genetic heterogeneity of hyperpepsinogenemic I and normopepsinogenemic I duodenal ulcer disease. Ann Intern Med (1979) 2.61
Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet (1995) 2.55
Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J Neurosci (2000) 2.51
Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med (1975) 2.35
Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation. Proc Soc Exp Biol Med (1970) 2.30
The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Intern Med (1970) 2.29
Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol (1975) 2.20
Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med (1983) 2.18
Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis. J Am Acad Dermatol (1990) 2.16
The G deletion syndromes. J Pediatr (1970) 2.09
Metaphyseal chondrodysplasia, Schmid type. Clinical and radiographic delineation with a review of the literature. Pediatr Radiol (1988) 2.06
Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med (1976) 2.04
Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol (1985) 1.96
Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol (2001) 1.91
Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis (2001) 1.89
Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol (1992) 1.84
Multiple vertebral segmentation defects: analysis of 26 new patients and review of the literature. Am J Med Genet (1996) 1.81
Precision of automatic measurements of pigmented skin lesion parameters with a MelaFind(TM) multispectral digital dermoscope. Melanoma Res (2000) 1.78
Identification by fluorescent microscopy of the abnormal chromosomes associated with the G-deletion syndromes. Am J Hum Genet (1973) 1.77
The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol (2000) 1.77
Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest (1986) 1.76
Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med (1997) 1.75
Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet (1984) 1.72
The lacrimo-auriculo-dento-digital syndrome. J Pediatr (1973) 1.67
Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet (1999) 1.67
Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia. Proc Natl Acad Sci U S A (1990) 1.66
Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: case report and review of the literature. Pediatr Hematol Oncol (1998) 1.64
Genetic aspects of clinical endocrinology. Recent Prog Horm Res (1968) 1.64
Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. Lab Invest (2000) 1.62
Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder. N Engl J Med (1979) 1.61
Spondylo-meta-epiphyseal dysplasia (SMED), short limb-hand type: a congenital familial skeletal dysplasia with distinctive features and histopathology. Am J Med Genet (1993) 1.60
Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med (1980) 1.60
Studies on lysosomes. XII. Redistribution of acid hydrolases in human lymphocytes stimulated by phytohemagglutinin. J Cell Biol (1968) 1.58
Geleophysic dysplasia: a storage disorder affecting the skin, bone, liver, heart, and trachea. J Pediatr (1990) 1.58
Dermatomyofibroma. A benign cutaneous, plaque-like proliferation of fibroblasts and myofibroblasts in young adults. J Cutan Pathol (1992) 1.55
Acute septic arthritis complicating chronic rheumatoid arthritis. JAMA (1966) 1.54
Incidence of and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. SEIEVA Collaborating Group. J Hepatol (1997) 1.51
Growth-hormone deficiency in man: an isolated, recessively inherited defect. Science (1966) 1.51
Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme. J Clin Invest (1979) 1.50
The long-term course of poststreptococcal glomerulonephritis. Ann Intern Med (1974) 1.50
Restoration of in-vitro lymphocyte responses with exogenous adenosine deaminase in a patient with severe combined immunodeficiency. Lancet (1975) 1.50
Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. Hum Mol Genet (1994) 1.49
Evidence for control of several different tissue-specific isozymes of adenosine deaminase by a single genetic locus. Nat New Biol (1973) 1.48
Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet (1999) 1.47
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. Am J Surg Pathol (1995) 1.44
Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene. Nat Genet (1996) 1.44
Syndrome of bilateral pheochromocytoma, medullary thyroid carcinoma and multiple neuromas. A possible regulatory defect in the differentiation of chromaffin tissue. N Engl J Med (1968) 1.43
Peptic ulcer disease--a heterogeneous group of disorders? Gastroenterology (1977) 1.42
The chondrodystrophies. Adv Hum Genet (1975) 1.42
Eruptive pseudoangiomatosis: a unique childhood exanthem? J Am Acad Dermatol (1993) 1.41
Genetic homogeneity of cartilage-hair hypoplasia. Hum Genet (1995) 1.39
Fetal varicella syndrome. J Pediatr (1987) 1.39
Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing. Pacing Clin Electrophysiol (1990) 1.39
Heterogeneity in diabetes mellitus--update, 1978. Evidence for further genetic heterogeneity within juvenile-onset insulin-dependent diabetes mellitus. Diabetes (1978) 1.38
Classification of osteogenesis imperfect. Lancet (1978) 1.37
Remission of the nephrotic syndrome in renal amyloidosis. N Engl J Med (1970) 1.35
A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII). Hum Mol Genet (1994) 1.35
Appearance of hydrolase rich granules in human lymphocytes induced by phytohemagglutinin and antigens. Blood (1967) 1.35
Spondylocostal dysplasia. A dominantly inherited form of short-trunked dwarfism. Am J Med (1968) 1.35
Phytohemagglutinin: inhibition of the agglutinating activity by N-acetyl-D-galactosamine. Science (1966) 1.34
A new variant of Ehlers-Danlos syndrome: an autosomal dominant disorder of fragile skin, abnormal scarring, and generalized periodontitis. Birth Defects Orig Artic Ser (1977) 1.33
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet (1998) 1.33
The hemolytic-uremic syndrome. Renal status of 76 patients at long-term follow-up. J Pediatr (1968) 1.32
Amerioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency. N Engl J Med (1980) 1.32
Standard growth curves for achondroplasia. J Pediatr (1978) 1.32
Template activity of nuclei from stimulated lymphocytes. Nature (1969) 1.31
Human X-autosome translocations: differential inactivation of the X chromosome in a kindred with an X-9 translocation. Am J Hum Genet (1975) 1.31
Close genetic linkage between diabetes mellitus and kidd blood group. Lancet (1981) 1.30
Morphologic studies in the skeletal dysplasias. Am J Pathol (1979) 1.29
Confirmation of the regional localization of the genes for human acid alpha-glucosidase (GAA) and adenosine deaminase (ADA) by somatic cell hybridization. Ann Hum Genet (1984) 1.28
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell (2001) 1.26
Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients. J Clin Invest (1981) 1.25
Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations. J Clin Invest (1976) 1.25
Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser (1979) 1.25
Cervicomedullary junction compression in infants with achondroplasia: when to perform neurosurgical decompression. Am J Hum Genet (1995) 1.24
Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am J Med Genet (1996) 1.23
A unique association of short stature, dysmorphic features, and speech impairment (Floating-Harbor syndrome). J Pediatr (1988) 1.23
Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis. J Clin Invest (1999) 1.23
Adenosine-deaminase deficiency in a child diagnosed prenatally. Lancet (1975) 1.22
Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet (1996) 1.22
Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases. Hematol Oncol Clin North Am (1999) 1.21
Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia. Am J Med Genet (1998) 1.21
Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience (2003) 1.21
Molecular-pathogenetic classification of genetic disorders of the skeleton. Am J Med Genet (2001) 1.20
Segregation of an insertional chromosome rearrangement in 3 generations. J Med Genet (1978) 1.20
Brachyolmia: radiographic and genetic evidence of heterogeneity. Am J Med Genet (1989) 1.20